Behavioral Health Software Market Worth $1.5 Billion by 2019

 

DALLASDecember 4, 2014 - According to the new market research report "Behavioral/Mental Health Software Market by Delivery Mode (Ownership & Subscription), Functionality (EHR, CDS, Telehealth, Payroll, RCM, Ledger, BI, Workforce & Case Management), End User (Hospitals, Clinics, Health Plans, Residential) - Forecasts to 2019", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the behavioral health software market along with the estimates and forecasts of the revenue and share analysis.

Browse 197 market data tables and 53 figures spread through 200 pages and in-depth TOC on"Behavioral/Mental Health Software Market"

http://www.marketsandmarkets.com/Market-Reports/behavioral-health-software-market-45953340.html    

Early buyers will receive 10% customization on this report.

The global Behavioral Health Software Market is expected to reach $1.5 Billion by 2019 from $0.75 Billion in 2014, growing at a CAGR of 14.7% from 2014 to 2019.

The report segments this market on the basis of component, delivery model, functionality and end user. Among various end users, the providers segment is expected to account for the largest share in 2014. Providers extensively use this software for maintaining patient records and management of revenue cycles and cases, which is a major reason for its high share. The residential end user segment is expected to grow at the highest CAGR from 2014 to 2019, due to the increasing use of behavioral health solutions by patients in their homes or offices for better self-care.

Based on geography, the global Behavioral Health Software Market is dominated by North America, followed by EuropeAsia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The growth of this market is driven by factors such as increasing government support for expanding behavioral health services, behavioral health reforms, and rising patient base seeking behavioral health services.

Further Inquiry:  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=45953340

Key players in the Behavioral Health Software Market include Netsmart Technologies (U.S.), Qualifacts (U.S.), Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), MindLinc (U.S.), Credible Behavioral Health Software (U.S.), Accumedic (U.S.), Askesis Development Group, Inc. (U.S.), BestNotes (U.S.), Valant Medical Solutions, Inc. (U.S.), Welligent, Inc. (U.S.), and NextGen Healthcare (U.S.), amongst others.

Browse related reports

Clinical Decision Support System (CDSS) Market by Product - Integrated (EHR, CPOE)], Model (Knowledge-based), Applications (Drug Allergy Alerts, Drug Interactions), Delivery Mode (Web-based, Cloud-based), Component (Hardware, Software) - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html

Population Health Management Market by Component (Software & Services), Delivery Mode (On-premise, Web, & Cloud), End-User (Provider, Payer, Employer Groups & Government Bodies) - Trends & Global Forecasts to 2018

http://www.marketsandmarkets.com/Market-Reports/population-health-management-market-263411936.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.